Factors affecting system clotting in continuous renal replacement therapy: Results of a randomized, controlled trial

Clinical Nephrology

Volumn 53, Issue 1, 2000, Pages 55-60

  Ramesh Prasad, G V ^a   Palevsky, P M ^a,b   Burr, R ^a   Lesko, J M ^a   Gupta, B ^a   Greenberg, A ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Continuous renal replacement therapy; Continuous venovenous hemodialysis; Thrombosis

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; FEMALE; FLUSHING; HEMODIALYSIS; HEPARINIZATION; HUMAN; KIDNEY FAILURE; MALE; THROMBOSIS;

ANALYSIS OF VARIANCE; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD FLOW VELOCITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; WHOLE BLOOD COAGULATION TIME;

EID: 0033984593     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bellomo R, Teede H, Boyce N 1993 Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. Intens Care Med 19: 329-332
2. Favre H, Martin PY, Stoermann C 1996 Anticoagulation in continuous extracorporeal renal replacement therapy. Semin Dial 9: 112-118
3. Flanigan MJ, Von Brecht JV, Freeman RM, Lim VS 1987 Reducing the hemorrhagic complications of hemodialysis - a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 9: 147-153
4. Jeffrey RF, Khan AA, Douglas JT, Will KJ, Davison AM 1993 Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit. Artif Organs 17: 717-720
5. Keller F, Seemann J, Preuschof L, Offermann G 1990 Risk factors for system clotting in heparin-free hemodialysis. Nephrol Dial Transplant 5: 802-807
6. Landefeld CS, Beyth RJ 1993 Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 95: 315-328
7. Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M 1994 Anticoagulation with prostacyclin and heparin during venovenous hemofiltration. Crit Care Med 22: 1774-1781
8. Lauer A, Saccagi A, Belledonne M, Glabman S, Bosch JP 1983 Continuous arteriovenous hemofiltration in the critically ill patient - clinical use and operational characteristics. Ann Intern Med 99: 455-460
9. Martin PY, Chevrolet JC, Suter P, Favre H 1994 Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 24: 806-812
10. Mehta R, McDonald B, Aguilar M, Ward D 1990 Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38: 976-981
11. Palevsky PM, Burr R, Moreland L, Tokiwa Y, Greenberg A 1995 Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy. ASAIO J 41: 847-649
12. Relton S, Greenberg A, Palevsky PM 1992 Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. ASAIO J 38: M691-M696
13. Sanders PW, Taylor H, Curtis JJ 1985 Hemodialysis without anticoagulation. Am J Kidney Dis 5: 32-35
14. Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Kostering H, Seidel D, Scheler F 1988 Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int 33: 890-896
15. Schwab SJ, Onorato JJ, Sharar LR, Dennis P 1987 Hemodialysis without anticoagulation. Am J Med 83: 405-410
16. Sigler MH, Teehan BP 1987 Solute transport in continuous hemodialysis: a new treatment for acute renal failure. Kidney Int 32: 562-571
17. Storck M, Hartl WH, Zimmerer E, Inthorn D 1991 Comparison of pump-driven and spontaneous continuous hemofiltration in postoperative acute renal failure. Lancet 337: 452-455